XML 68 R47.htm IDEA: XBRL DOCUMENT v3.22.1
Share-based Payments (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Summary of the Activity Under the Share Option Scheme
A summary of the activity under the Share Option Scheme is stated below:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
Number of

options
   
Weighted-

average exercise

price
    
Weighted-

average

grant-date

fair value
    
Weighted-

average

remaining

contractual term
    
Aggregate

intrinsic

value
 
          
US$
    
US$
    
Years
    
US$
 
Outstanding, December 31, 2020
     86,759,375       0.07        0.54        7.12        2.83  
Granted
     12,292,710       0.07        2.80                    
Forfeited
     (7,384,942     0.07        1.38                    
Exercised
     (29,906,941     0.07        0.71                    
    
 
 
                                    
Outstanding, December 31, 2021
     61,760,202       0.07        0.87        6.61        0.98  
    
 
 
                                    
Vested and expected to vest at December 31, 2021
     61,760,202       0.07        0.87        6.61        0.98  
    
 
 
                                    
Exercisable at December 31, 2021
     28,437,976       0.07        0.46        5.22        0.98  
    
 
 
                                    
Summary of the Activity for the Restricted Shares Issued Under the Share Award Scheme
A summary of the activity for the restricted shares issued under the Share Award Scheme is stated below:
 
 
 
 
 
 
 
 
 
 
    
Number of

shares
    
Weighted-average

grant date fair value
 
           
US$
 
Outstanding, December 31, 2020
     53,602,560        0.76  
Granted
     29,076,828        2.04  
Vested
     (19,020,640      0.71  
Forfeited
     (5,671,482      1.61  
    
 
 
    
 
 
 
Outstanding, December 31, 2021
     57,987,266        1.32  
    
 
 
    
 
 
 
Expected to vest at December 31, 2021
     57,987,266        1.32  
    
 
 
    
 
 
 
Summary of the Activity for the Restricted Shares Issued Under the Share Award Scheme
A summary of the activity for the options issued under the Share Award Scheme is stated below:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
Number of

options
   
Weighted-

average exercise

price
    
Weighted-

average

grant-

date

fair value
    
Weighted-

average

remaining

contractual term
    
Aggregate

intrinsic

value
 
          
US$
    
US$
    
Years
    
US$
 
Outstanding, December 31, 2020
     37,191,840       0.82        0.31        9.00        2.09  
Exercised
     (8,081,820     0.64        0.33                    
Forfeited
     (1,241,600     0.87        0.30                    
    
 
 
                                    
Outstanding, December 31, 2021
     27,868,420       0.83        0.31        7.99        0.22  
    
 
 
                                    
Vested and expected to vest at December 31, 2021
     27,868,420       0.83        0.31        7.99        0.22  
    
 
 
                                    
Exercisable at December 31, 2021
     12,566,340       0.80        0.30        8.00        0.25  
    
 
 
                                    
Summary of Assumptions Used To Estimate the Fair Value of the Share Options
The estimated fair values of the ordinary shares, at the share award grant dates, was determined with the assistance from an independent third-party valuation firm. The assumptions used to estimate the fair value of the share options granted are as follows:
 
 
 
 
 
 
 
 
   
For the year ended December 31
   
2019
 
2020
 
2021
Risk-free rate
 
1.58%-1.80%
 
0.66%-1.84%
 
1.13%-1.62%
Expected volatility range
 
37.40%-37.90%
 
37.3%-37.8%
 
36.28%-38.03%
Exercise multiple
 
2.20-2.80
 
2.20-2.80
  2.20-2.80
Fair market value per ordinary share as at valuation dates
 
US$0.72-US$0.76
 
US$0.76-US$1.94
 
US$1.97-US$3.49
Summary of acquisition date fair value of each share-based award is estimated
The acquisition date fair value of each Camelot award is estimated on the date of modification using the binomial tree option pricing model with the following assumptions:
 
 
  
2021
 
Risk-free rate
     0.21
Expected volatility range
     50.56
Exercise multiple
     2.20  
Fair market value per Camelot’s ordinary share
     RMB23.00  
Summary of Share-based Compensation Expense
The following table sets forth the amount of share-based compensation expense included in each of the relevant financial statement line items:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
For the year ended December 31
 
    
2019
    
2020
    
2021
    
2021
 
    
RMB
    
RMB
    
RMB
    
US$
 
Cost of revenues
     8,509        10,614        17,481        2,743  
Selling and marketing expenses
     37,808        62,270        72,594        11,392  
General and administrative expenses
     31,988        169,101        193,886        30,425  
Research and development expenses
     42,974        88,129        150,389        23,599  
    
 
 
    
 
 
    
 
 
    
 
 
 
       121,279        330,114        434,350        68,159